TipRanks
ImmunityBio (DE:26CA)
XETRA:26CA
Germany Market
26CA
ImmunityBio
RESEARCH TOOLSreports

ImmunityBio (26CA) Stock News & Sentiment

17 Followers
ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market Potential
Premium
Company Announcements
ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market Potential
6d ago
IBRX
ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should Know
Premium
Company Announcements
ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should Know
7d ago
IBRX
What 235,000 Stock Periods Suggest About Revenue Growth and Returns: Inside the Golden Eagle Dynamic Hypergrowth ETF (HYP)
Premium
Market NewsSponsored
What 235,000 Stock Periods Suggest About Revenue Growth and Returns: Inside the Golden Eagle Dynamic Hypergrowth ETF (HYP)
7d ago
BE
MU
ImmunityBio (IBRX) Faces Investor Scrutiny as Defendants Move to Dismiss Securities Lawsuit Over Podcast Statements
Premium
Class Action
ImmunityBio (IBRX) Faces Investor Scrutiny as Defendants Move to Dismiss Securities Lawsuit Over Podcast Statements
7d ago
IBRX
BTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target
Premium
Ratings
BTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target
2M ago
IBRX
ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target
Premium
Ratings
ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target
2M ago
IBRX
ImmunityBio wins UAE approval for ANKTIVA cancer therapies
Premium
Company Announcements
ImmunityBio wins UAE approval for ANKTIVA cancer therapies
2M ago
8K
IBRX
More DE:26CA News >

26CA News on the Web

A $5.8B Cancer Market Opportunity Is Emerging — Why GA-Courtenay Favors ImmunityBio (IBRX)
Insider Monkey
Bullish
What 235,000 Stock Periods Suggest About Revenue Growth and Returns: Inside the Golden Eagle Dynamic Hypergrowth ETF (HYP)
TipRanks News
Neutral
ImmunityBio Stock Sinks as Speculative Rally Unravels
TipRanks News
Neutral
ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%
Insider Monkey
Bullish
ImmunityBio Soars On New Trial Tease And Expansion Hopes
TipRanks News
Bullish
Is ImmunityBio Inc (IBRX) Worth the Investment? Q2 Revenue Surges to $50.7 Million Amid $230. ...
GuruFocus News
Neutral
Biotech High‑Flyer ImmunityBio Suddenly Hits a Wall
TipRanks News
Neutral
Insider Stock Sale Sends ImmunityBio Shares Sinking
TipRanks News
Neutral

News Score - Last 7 Days

Positive
DE:26CA
Sector Average
Media Buzz
This Week5 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:26CA’s Media Buzz Sentiment?
5 articles about DE:26CA were published this week. In an average week, 3.75 articles are published.
    What is DE:26CA’s weekly average amount of articles?
    In an average week, 3.75 articles about DE:26CA are published.
      What is DE:26CA’s News Sentiment?
      100% of articles about DE:26CA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week